BACKGROUND: Postdischarge use of evidence-based drug therapies has been proposed as a measure of quality of care for myocardial infarction patients. We examined trends in the use of evidence-based drug therapies after discharge among elderly patients with myocardial infarction. METHODS: We performed a cross-sectional study in a retrospective population-based cohort that was created using linked administrative databases. We included patients aged 65 years and older who were discharged from hospital with a diagnosis of myocardial infarction between Apr. 1, 1992, and Mar. 31, 2005. We determined the annual percentage of patients who filled a prescription for statins, beta-blockers and angiotensin-modifying drugs within 90 days after discharge. RESULTS: The percentage of patients who filled a prescription for a beta-blocker increased from 42.6% in 1992 to 78.1% in 2005. The percentage of patients who filled a prescription for an angiotensin-modifying drug increased from 42.0% in 1992 to 78.4% in 2005. The percentage of patients who filled a prescription for a statin increased from 4.2% in 1992 to 79.2% in 2005. In 2005, about half of the hospitals had rates of use for each of these therapies that were less than 80%. The temporal rate of increase in statin use after discharge was slower among noncardiologists than among cardiologists (3.5%-2.8% slower). The rate of increase was 4.8% slower for among physicians with low volumes of myocardial infarction patients than among those with high volumes of such patients and was 5.7% greater at teaching hospitals compared with nonteaching hospitals. INTERPRETATION: Use of statins, beta-blockers and angiotensin-modifying drugs increased from 1992 to 2005. The rate of increase in the use of these medications after discharge varied across physician and hospital characteristics.
BACKGROUND: Postdischarge use of evidence-based drug therapies has been proposed as a measure of quality of care for myocardial infarctionpatients. We examined trends in the use of evidence-based drug therapies after discharge among elderly patients with myocardial infarction. METHODS: We performed a cross-sectional study in a retrospective population-based cohort that was created using linked administrative databases. We included patients aged 65 years and older who were discharged from hospital with a diagnosis of myocardial infarction between Apr. 1, 1992, and Mar. 31, 2005. We determined the annual percentage of patients who filled a prescription for statins, beta-blockers and angiotensin-modifying drugs within 90 days after discharge. RESULTS: The percentage of patients who filled a prescription for a beta-blocker increased from 42.6% in 1992 to 78.1% in 2005. The percentage of patients who filled a prescription for an angiotensin-modifying drug increased from 42.0% in 1992 to 78.4% in 2005. The percentage of patients who filled a prescription for a statin increased from 4.2% in 1992 to 79.2% in 2005. In 2005, about half of the hospitals had rates of use for each of these therapies that were less than 80%. The temporal rate of increase in statin use after discharge was slower among noncardiologists than among cardiologists (3.5%-2.8% slower). The rate of increase was 4.8% slower for among physicians with low volumes of myocardial infarctionpatients than among those with high volumes of such patients and was 5.7% greater at teaching hospitals compared with nonteaching hospitals. INTERPRETATION: Use of statins, beta-blockers and angiotensin-modifying drugs increased from 1992 to 2005. The rate of increase in the use of these medications after discharge varied across physician and hospital characteristics.
Authors: M D Flather; S Yusuf; L Køber; M Pfeffer; A Hall; G Murray; C Torp-Pedersen; S Ball; J Pogue; L Moyé; E Braunwald Journal: Lancet Date: 2000-05-06 Impact factor: 79.321
Authors: F C Dwamena; H El-Tamimi; R E Watson; J Kroll; A D Stein; A McLane; M Holmes-Rovner; B McIntosh; J Kupersmith Journal: Clin Cardiol Date: 2000-05 Impact factor: 2.882
Authors: Frederick A Masoudi; JoAnne M Foody; Edward P Havranek; Yongfei Wang; Martha J Radford; Richard M Allman; Jay Gold; R Todd Wiblin; Harlan M Krumholz Journal: Circulation Date: 2006-12-04 Impact factor: 29.690
Authors: Dennis T Ko; Alice M Newman; David A Alter; Peter C Austin; Maria Chiu; Jafna L Cox; Shaun G Goodman; Jack V Tu Journal: Can J Cardiol Date: 2010-03 Impact factor: 5.223
Authors: Andrea V Margulis; Niteesh K Choudhry; Colin R Dormuth; Sebastian Schneeweiss Journal: Pharmacoepidemiol Drug Saf Date: 2011-04-28 Impact factor: 2.890
Authors: Lisa M Miller; Manish M Sood; Amy R Sood; Martina Reslerova; Paul Komenda; Claudio Rigatto; Joe Bueti Journal: Int Urol Nephrol Date: 2010-10-20 Impact factor: 2.370
Authors: Vera Bittner; Lisandro D Colantonio; Yuling Dai; Mark Woodward; Matthew T Mefford; Robert S Rosenson; Paul Muntner; Keri L Monda; Meredith L Kilgore; Byron C Jaeger; Emily B Levitan Journal: JAMA Cardiol Date: 2019-09-01 Impact factor: 14.676